Back to Journals » Drug Design, Development and Therapy » Volume 15

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

Total article views   HTML views PDF downloads Totals
5,475 Dovepress* 4,907+ 400 5,307
PubMed Central* 568 168 736
Totals 5,475 568 6,043
*Since 6 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar